--- title: "Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors" type: "News" locale: "en" url: "https://longbridge.com/en/news/292532937.md" description: "Charles River Laboratories International Inc. (CRL) shares fell 1.57% to $229.75 on Monday, underperforming the broader market and its peers during a grim trading session. This marks the stock's second consecutive day of losses, leaving it 3.41% below its 52-week high. Trading volume exceeded the 50-day average." datetime: "2026-07-13T21:16:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292532937.md) - [en](https://longbridge.com/en/news/292532937.md) - [zh-HK](https://longbridge.com/zh-HK/news/292532937.md) generator: "portal-rs" --- # Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Charles River Laboratories International Inc. (CRL) shed 1.57% to $229.75 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.79% to 7,515.34 and Dow Jones Industrial Average falling 0.26% to 52,498.64. This was the stock's second consecutive day of losses. Charles River Laboratories International Inc. closed 3.41% short of its 52-week high of $237.86, which the company reached on July 10th. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Labcorp Holdings Inc. (LH) fell 0.05% to $276.68, Alnylam Pharmaceuticals Inc. (ALNY) fell 3.58% to $288.06, and Bio-Techne Corp. (TECH) rose 0.08% to $71.36. Trading volume (910,091) eclipsed its 50-day average volume of 896,602. Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 07-13-26 1716ET ### Related Stocks - [CRL.US](https://longbridge.com/en/quote/CRL.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [LH.US](https://longbridge.com/en/quote/LH.US.md) - [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md) - [TECH.US](https://longbridge.com/en/quote/TECH.US.md) ## Related News & Research - [Charles River Laboratories Earnings Preview: What to Expect](https://longbridge.com/en/news/293235736.md) - [Charles River director James C. Foster disposes of USD 10.07 million in common shares](https://longbridge.com/en/news/297228922.md) - [Insider Move at Charles River Labs: Director Cashes In on Company Stock](https://longbridge.com/en/news/296571643.md) - [Charles River Labs director Nancy C. Andrews disposes of 573 common shares worth $163,442.52](https://longbridge.com/en/news/296533503.md) - [Charles River Labs CEVP Shannon Parisotto disposes of shares worth $1,038,051.24](https://longbridge.com/en/news/295844385.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**